Watson Pharmaceuticals Looks Set For More Growth
In the pharmaceuticals business, it's common nowadays to adopt a shotgun approach. Create or buy hundreds of chemical ideas, test them, and see whether one or a few of them can become the next billion-dollar drug. Watson Pharmaceuticals (WPI) is no exception to this strategy. The company owns more than 750 distinct molecules that are offered in more than 1,700 dosage combinations. It sells these molecules in the form of generics, branded generics
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here